AEGIR-INSIGHTS
15.11.2023 08:31:36 CET | Business Wire | Press release
Aegir Insights, a sector leader in software and technology-driven intelligence for offshore wind investment, is proud to welcome Metsähallitus as a client for its suite of workflow software, data and intelligence for offshore wind.
Aegir Insights provides a competitive edge to offshore wind developers, investors and governments by combining deep industry experience with advanced data science and proprietary analytics models to assess offshore wind (investment) opportunities, helping global renewable players and governments make smarter strategic decisions faster, accelerating the deployment of renewables. Aegir’s advanced solutions Aegir Quant and Aegir GAMMA are helping governments to form the policy and strategy for large scale deployment of offshore wind.
“The Finnish Government has set the goal of establishing Finland as a fossil-free society by 2035. As the administrator of state-owned land and water areas, Metsähallitus has an important role to play in achieving these climate targets.” says Scott Urquhart, CEO of Aegir Insights. “We are happy to now have Metsähallitus onboard under an Aegir.Gov. agreement, with deployment of our solutions helping support Metsähallitus’ offshore wind tendering processes and helping Finland’s market development”
Metsähallitus has recently launched an international competitive tendering process for offshore wind power projects off Närpiö and Raahe and Pyhäjoki. According to Metsähallitus, the planned total capacity of the two new offshore wind farms is approximately 3,000 MW.
Markku Tuominen, Wind Power Manager, Metsähallitus says “We are extremely pleased to enter a cooperation agreement with Aegir Insights and look forward to tapping into their deep offshore wind industry insights and experience, as well as benefiting from their advanced tool chain and software products to support Metsähallitus’ remit in offshore wind market development in Finland”
Delivering both comprehensive and instantaneous results for large swathes of sea area, Aegir GAMMA (Geospatial Analytics Model and Mapping tool) will assist Metsähallitus in identifying optimal areas for future offshore wind development.
Aegir Quant is an investment workflow solution which allows offshore wind developers and governments to carry out advanced simulation of offshore wind projects and portfolios for both fixed-bottom and floating wind. Applications include offshore wind project and portfolio development, M&A screening, bid analysis and feasibility assessments.
About Aegir Insights
Smarter, faster, greener.
Aegir Insights provides premium commercial analytics and models to help inform investment strategy and capital allocation for leading players in the offshore wind and power-to-x (PtX) sectors.
Aegir Insights’ differentiated strategy includes its technology-led approach in cooperation with clients and academia, and its senior team having more than 70 years of industry experience from leading developers and OEMs including Orsted, Vattenfall, Vestas and Siemens.
Aegir Insights also serves as a trusted government advisor in development of offshore wind and PtX markets.
To learn more visit: www.aegirinsights.com
About Metsähallitus
Metsähallitus is a state enterprise that manages one third of Finland's land and water areas. Metsähallitus aims to foster the value of nature and shared wealth in a responsible manner across generations. 1,200 Metsähallitus employees all over Finland are responsible for the sustainable use, management and protection of these land and water areas, reconciling different needs and expectations.
To learn more visit: www.metsa.fi/en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231114072642/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom